Tech Company Financing Transactions
Cellcolabs Funding Round
On 10/27/2025, Cellcolabs raised $12 million in funding from Titian Capital.
Transaction Overview
Company Name
Announced On
10/27/2025
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Proceeds Purpose
With this investment, Cellcolabs plans to advance technical development and expand internationally, reinforcing its objective to increase the accessibility and affordability of high-quality MSCs for research and therapeutic use.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Retzius väg 8
Solna, 171 65
Sweden
Solna, 171 65
Sweden
Phone
Undisclosed
Website
Email Address
Overview
Cellcolabs is a biotech company specialising in Industrial GMP production of high quality stem cells (Mesenchymal Stem Cells). The company is founded on the research conducted by Professor Katarina Le Blanc and co-founded by healthcare entrepreneur Per Båtelson, Maria Rankka and Norrsken. For two decades, Katarina's team at the Karolinska Institute has been dedicated to advancing stem cell research.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Maria Rankka
Chief Executive Officer
Mattias Bernow
Chief Medical Officer
Heidi Stensmyren
Chief Operating Officer
Petter Hallman
VP - Bus. Development
Michael Luxemburg
VP - Manufacturing
Lina Sörvik
VP - R & D
Nadir Kadri
VP - Regulatory Affairs
Linda Ranehamn
Browse more venture capital transactions:
Prev: 10/27/2025: SavvyMoney venture capital transaction
Next: 10/27/2025: Hemab Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs